Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$191M |
| 2 |
Dominion Energy
D
|
+$178M |
| 3 |
Capital One
COF
|
+$166M |
| 4 |
Range Resources
RRC
|
+$100M |
| 5 |
Nabors Industries
NBR
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$342M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$319M |
| 3 |
JPMorgan Chase
JPM
|
+$283M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Bank of America
BAC
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.54% |
| 2 | Consumer Discretionary | 14.77% |
| 3 | Healthcare | 10.49% |
| 4 | Real Estate | 8.06% |
| 5 | Technology | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AQ
1726
DELISTED
Aquantia Corp. Common Stock
AQ
| $221K | ﹤0.01% |
+14,066
| New | +$196K |
|
1727
Byline Bancorp
BY
$1.72B
| $220K | ﹤0.01% |
+9,587
| New | +$218K |
|
1728
Mercantile Bank Corp
MBWM
$1.04B
| $219K | ﹤0.01% |
+6,573
| New | +$230K |
|
1729
Oppenheimer Holdings
OPY
$1.24B
| $219K | ﹤0.01% |
8,500
-900
| -10% | -$24.2K |
|
1730
Voyager Therapeutics
VYGR
$214M
| $219K | ﹤0.01% |
11,675
-152,136
| -93% | -$3.29M |
|
|
CUTR
1731
DELISTED
Cutera, Inc.
CUTR
| $219K | ﹤0.01% |
+4,356
| New | +$213K |
|
|
GBNK
1732
DELISTED
Guaranty Bancorp
GBNK
| $219K | ﹤0.01% |
+7,709
| New | +$220K |
|
1733
J&J Snack Foods
JJSF
$1.67B
| $218K | ﹤0.01% |
+1,593
| New | +$224K |
|
1734
Matador Resources
MTDR
$6.87B
| $217K | ﹤0.01% |
+7,245
| New | +$220K |
|
1735
Universal Display
OLED
$4.11B
| $217K | ﹤0.01% |
2,144
+444
| +26% | +$66.7K |
|
|
NETI
1736
DELISTED
Eneti Inc.
NETI
| $217K | ﹤0.01% |
3,305
-2,102
| -39% | -$151K |
|
1737
Enova International
ENVA
$6.06B
| $216K | ﹤0.01% |
9,800
-3,600
| -27% | -$72.4K |
|
1738
Varex Imaging
VREX
$780M
| $216K | ﹤0.01% |
+6,050
| New | +$231K |
|
|
CBM
1739
DELISTED
Cambrex Corporation
CBM
| $216K | ﹤0.01% |
4,127
-91,287
| -96% | -$4.88M |
|
1740
Cerus
CERS
$548M
| $214K | ﹤0.01% |
39,000
+17,200
| +79% | +$78.2K |
|
1741
1st Source
SRCE
$2.07B
| $213K | ﹤0.01% |
4,200
-4,500
| -52% | -$231K |
|
1742
Ironwood Pharmaceuticals
IRWD
$725M
| $211K | ﹤0.01% |
+16,324
| New | +$203K |
|
1743
Preferred Bank
PFBC
$1.23B
| $211K | ﹤0.01% |
3,280
-1,400
| -30% | -$89.3K |
|
1744
Syndax Pharmaceuticals
SNDX
$1.78B
| $211K | ﹤0.01% |
14,813
-33,993
| -70% | -$361K |
|
|
VRNT
1745
DELISTED
Verint Systems
VRNT
| $211K | ﹤0.01% |
+9,707
| New | +$200K |
|
|
ATRI
1746
DELISTED
Atrion Corp
ATRI
| $211K | ﹤0.01% |
334
-200
| -37% | -$117K |
|
|
HZN
1747
DELISTED
Horizon Global Corporation
HZN
| $211K | ﹤0.01% |
+25,568
| New | +$256K |
|
1748
Standex International
SXI
$3.69B
| $210K | ﹤0.01% |
+2,202
| New | +$220K |
|
|
CALA
1749
DELISTED
Calithera Biosciences, Inc
CALA
| $210K | ﹤0.01% |
1,669
-691
| -29% | -$108K |
|
1750
QuidelOrtho
QDEL
$1.03B
| $209K | ﹤0.01% |
+4,043
| New | +$188K |
|
Similar funds
Dmitry Balyasny's Q1 2018 Portfolio in Review
As of Q1 2018, Dmitry Balyasny held 2,587 positions worth $23.9B, down 25% from $32B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny withdrew a net $7.84B in Q1 2018, closing 702 positions and reducing 627 holdings. Its most notable exit was Travelers Companies, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Range Resources worth $97.4M.
- Dmitry Balyasny's largest Q1 2018 buy was Range Resources: 6,699,750 shares worth $97.4M.
- Dmitry Balyasny added most to Walt Disney in Q1 2018, an estimated $191M increase.
- Dmitry Balyasny's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $319M.
- Dmitry Balyasny fully exited Travelers Companies in Q1 2018, selling an estimated $342M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $23.9B portfolio in Q1 2018.
- Dmitry Balyasny opened 563 new positions and closed 702 in Q1 2018.
- Dmitry Balyasny's portfolio value fell 25% quarter-over-quarter to $23.9B.
Based on Balyasny Asset Management's 13F filing for Q1 2018, filed 15 May 2018.